J Cancer Prev.  2018 Sep;23(3):126-133. 10.15430/JCP.2018.23.3.126.

Application of the Adverse Outcome Pathway Framework to Risk Assessment for Predicting Carcinogenicity of Chemicals

Affiliations
  • 1Institute of Environmental Medicine for Green Chemistry, Department of Life Science, Dongguk University Biomedi Campus, Goyang, Korea. seoyr@dongguk.edu
  • 2Department of Chemical and Biological Engineering, College of Natural Science and Engineering, Seokyeong University, Seoul, Korea.
  • 3Department of Preventive Medicine and Institute of Occupational and Environmental Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.
  • 4Faculty of Health Science, Daegu Haany University, Gyeongsan, Korea.

Abstract

As industry develops in modern society, many chemicals are being used. The safety of chemicals is an important issue because humans are constantly exposed to chemicals throughout their daily life. Through a risk assessment, the hazardous human effects of chemicals can be identified. Recently, the adverse outcome pathway (AOP) framework has been used to predict the adverse effects of chemicals. As a conceptual framework for organizing existing biological knowledge, the AOP consists of a molecular initiating event, key events, and an adverse outcome. These independent elements represent biological responses and are connected by key event relationships. This AOP framework provides intuitive hazard identification that can be helpful for carcinogenic risk assessment of chemicals. In this review, we introduce the application of the AOP framework to risk assessment for predicting carcinogenicity of chemicals and illustrate the utility of this approach for cancer prevention.

Keyword

Chemical safety; Adverse outcome pathways; Carcinogenesis; Risk assessment

MeSH Terms

Carcinogenesis
Chemical Safety
Humans
Risk Assessment*
Full Text Links
  • JCP
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr